Besides these two types of diseases, REV-ERBα has been implicated in the development of many other disorders such as hypercholesterolemia, obesity, dyslipidemia, and diabetes (Zhang et al., 2018b; Yuan et al., 2019; Zhang et al., 2019). Here, NR1D1 is linked to obesity due to melanocortin 4 receptor deficiency.